Bletilla striata-based gastric mucosa surface hemostasis and repair microsphere capsule and preparation method thereof

By combining Bletilla polysaccharide with pectin phospholipid complex, surface concave-convex microsphere capsules are prepared using self-microemulsion drug delivery system and electrostatic dropping technology, which solves the problem of how Bletilla accurately targets gastric mucosa damage and achieves significant gastric mucosa. Prolong the hemostasis and repair effects and efficacy.

CN118903053AActive Publication Date: 2024-11-08WUHAN TEXTILE UNIV
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202410686328.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-30
Publication Date
2024-11-08
Estimated Expiration
2044-05-30

AI Technical Summary

Technical Problem

The prior art is difficult to solve gastric mucosa damage and bleeding problems through good biocompatibility and significant therapeutic effects. In particular, how to use Bletilla striata as the main drug and accurately target it to the gastric mucosa damage site to exert its efficacy.

Method used

Bletilla striata polysaccharide and pectin phospholipid complex are used to combine, and microsphere capsules with surface concave and convex structures are prepared through the self-microemulsion drug delivery system as the drug carrier, and electrostatic field dropping technology is used to prepare microsphere capsules with a surface concave and convex structure to achieve directional hemostasis and repair.

Benefits of technology

The targeted aggregation of Bletilla pectin phospholipid complex in the damaged site of gastric ulcer oxidative stress is achieved, forming a thin film, closely fitting the gastric mucosa, prolonging the drug action time, improving the efficacy, and reducing gastric acid stimulation and promoting gastric mucosa repair.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903053A_ABST
    Figure CN118903053A_ABST
Patent Text Reader

Abstract

The invention provides a bletilla striata-based gastric mucosa surface hemostatic repair microsphere capsule. The bletilla striata-based gastric mucosa surface hemostatic repair microsphere capsule is prepared by adopting the following method: firstly, stirring and mixing a bletilla striata polysaccharide solution and a pectin solution to prepare a viscous mixture, and standing; uniformly mixing the viscous mixture with lecithin in an organic solvent to prepare a bletilla pectin phospholipid compound; adding the bletilla striata pectin phospholipid complex into a self-microemulsion drug delivery system to prepare transparent liquid; dropwise adding the transparent liquid into an aqueous solution dissolved with carboxymethyl chitosan and acetic acid in an electrostatic field, then adding a sodium citrate aqueous solution to prepare gel microspheres with a shell structure, and standing to obtain microspheres with concave-convex surfaces; curing and freeze-drying the microspheres with the concave-convex surfaces, so as to obtain the bletilla striata-based gastric mucosa surface hemostasis and repair microsphere capsule. The microsphere capsule provided by the invention can realize the efficient bleeding stopping and repairing functions of the gastric mucosa surface, has natural and safe components and small side effects, and is suitable for treating various gastric mucosa injuries and bleeding.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention provides a gastric mucosal surface hemostasis and repairing microsphere capsule based on bletilla striata and a preparation method thereof, belonging to the technical field of biomedicine. Background Art

[0002] Gastric mucosal injury and bleeding are common digestive system diseases in clinical practice. The gastric mucosa is the inner wall tissue of the stomach. When the gastric mucosa is damaged, it may cause serious consequences such as bleeding, which seriously affects the patient's life and health. At present, most of the commonly used gastric mucosal repair and hemostatic drugs in clinical practice are chemical synthetic drugs. Although they have certain therapeutic effects, they still have certain problems in terms of therapeutic effects and side effects, and long-term use is prone to drug resistance. In recent years, with the development of the biomedicine field, the development of a biomedicine for hemostatic repair of the gastric mucosal surface with good biocompatibility and significant efficacy has gradually become a research hotspot in this field.

[0003] In the prior art, the DOI is: 10.7501 / j.issn.0253-2670.2024.01.018, and the publication date is January 2024. The journal named "Evaluation of Gastric Ulcer Targeting Effect and Protective Effect of Evodiamine Phospholipid Complex Self-Microemulsion Delivery System" evaluated the gastric ulcer targeting of evodiamine phospholipid complex by analyzing the fluorescence imaging results and the laser confocal microscope fluorescence imaging results. The evodiamine phospholipid complex has a good protective effect on the ethanol-induced rat gastric ulcer model. The preparation mainly relieves the symptoms of gastric diseases through its anti-inflammatory, analgesic and anti-ulcer effects, rather than exerting its therapeutic effect by protecting the gastric mucosa, promoting ulcer healing and inhibiting the growth of Helicobacter pylori, and cannot better solve the problem of gastric disease from the root.

[0004] Bletilla striata is a perennial herbaceous plant of the orchid family, and is used as a hemostatic material in traditional Chinese medicine. Bletilla striata polysaccharide has good water absorption and swelling properties, can absorb a large amount of water and swell in a short time, has good tissue compatibility, bioadhesion, biodegradability, and is non-irritating to the mucosa, and has a wide range of application value in the field of biomedical technology. The mucus and starch contained in Bletilla striata can cover the damaged gastric mucosa, forming a protective layer, reducing the stimulation of gastric acid, pepsin, etc. to the mucosa. At the same time, the active ingredients in Bletilla striata can promote epidermal cell proliferation and accelerate the repair process of the ulcer surface. However, how to use Bletilla striata as the main drug and accurately target the gastric mucosal injury site to make it play a targeted effect is a problem that has not yet been solved in this field. Summary of the invention

[0005] In response to the problems in the background technology, the present application specifically provides a gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata. The microsphere capsule utilizes the water absorption and swelling characteristics of Bletilla striata and uses a self-microemulsification drug delivery system as a targeted and fixed-point drug carrier. At the same time, combined with the special concave-convex structure of the microspheres on the surface of the microsphere capsule, it is attached to the surface of the gastric ulcer, thereby realizing the function of directional hemostatic repair.

[0006] The technical solution adopted to achieve the above-mentioned purpose of the present invention is:

[0007] A gastric mucosal surface hemostasis and repairing microsphere capsule based on Bletilla striata, wherein the microsphere capsule is prepared by the following method:

[0008] (1) stirring and mixing the bletilla striata polysaccharide solution and the pectin solution in a volume ratio of 1:1 to 3:1 to obtain a viscous mixture and letting it stand;

[0009] (2) mixing the viscous mixture and lecithin in an organic solvent at a mass ratio of 1:2 to 2:1, and then removing the organic solvent to obtain a bletilla striata pectin phospholipid complex;

[0010] (3) adding the bletilla striata pectin phospholipid complex into the self-microemulsion drug delivery system and fully dissolving it to obtain a transparent liquid;

[0011] (4) adding the transparent liquid dropwise to an aqueous solution containing carboxymethyl chitosan and acetic acid under the action of an electrostatic field, then adding an aqueous solution of sodium citrate, and continuing to stir for secondary crosslinking to obtain gel microspheres with a shell structure, and allowing the gel microspheres to stand at room temperature to obtain microspheres with concave-convex surfaces after gravity sedimentation;

[0012] (5) The surface convex-concave microspheres are solidified under ultraviolet light, and part of the sodium citrate in the shell layer is washed off in an alkaline solution. After precooling, the microspheres are placed in a freeze dryer for freeze drying, thereby obtaining gastric mucosal surface hemostatic repair microsphere capsules based on Bletilla striata.

[0013] Furthermore, the microsphere capsule is spherical as a whole, with a particle size of 8 to 10 μm, and is coated with an inner core layer and an outermost layer, wherein the inner core layer is a bletilla polysaccharide-pectin-lecithin complex; and the outermost layer is a carboxymethyl chitosan coating layer, which has a concave-convex surface structure.

[0014] Furthermore, the preparation method of the bletilla striata polysaccharide solution in step (1) is as follows:

[0015] Add Bletilla striata polysaccharide to deionized water to prepare a Bletilla striata polysaccharide solution with a mass fraction of 3 to 10%, use a magnetic stirrer to stir at a temperature of 50°C to 70°C for 2h to 4h to completely dissolve the Bletilla striata polysaccharide in the deionized water, and place it in a vacuum environment with a vacuum degree of -0.01 to -0.05Mpa to remove bubbles to obtain a Bletilla striata polysaccharide solution.

[0016] Furthermore, the extraction method of the bletilla striata polysaccharide is as follows:

[0017] a1. Soak the dried Bletilla striata stems with distilled water at a mass ratio of 1:3 to 1:10, filter through gauze to remove impurities, collect the preliminarily cleaned Bletilla striata stems and dry them in an oven at 30 to 50°C for 18 to 24 hours;

[0018] a2. Soak the initially cleaned and dried Bletilla striata stems in anhydrous ethanol for 1 to 3 hours at a temperature of 20 to 30°C, filter through gauze to remove soluble pigments, collect Bletilla striata stems and dry them in an oven for 18 to 24 hours;

[0019] a3. Take the white striata stems after removing the pigment and soak them in distilled water in a mass ratio of 1:3 to 1:10, soak for 0.5 to 3 hours, soak at a temperature of 50 to 90 ° C, use a magnetic stirrer, stir the mixture continuously at room temperature for about 2 hours to ensure thorough mixing; transfer the mixture to a hot water bath, heat to 95 ° C, maintain the temperature for 1 hour, and after heating, cool the mixture to room temperature;

[0020] a4. Centrifuge the mixture to separate the crude polysaccharide solution, collect the supernatant, and filter the supernatant using a filter and filter paper to remove residual impurities;

[0021] a5. The filtered solution was concentrated in an evaporator at low temperature until the volume of the solution was reduced to 1 / 3 to 2 / 1 of the original volume, and an equal volume of 80% to 100% ethanol was added to the concentrated solution, mixed evenly, and allowed to stand overnight to precipitate polysaccharides to obtain a Bletilla striata polysaccharide concentrate;

[0022] a6. The precipitate is cleaned 2 to 3 times by static cleaning, flushing cleaning or ultrasonic cleaning, each cleaning time is 1 to 5 minutes, and the cleaned Bletilla striata polysaccharide is placed in an oven for drying at a drying temperature of 40 to 80° C. to obtain dried Bletilla striata polysaccharide.

[0023] Furthermore, the preparation method of the pectin solution in step (1) is as follows:

[0024] a1. The pretreated citrus peel was crushed to obtain a powder, and then soaked in a certain concentration of hydrochloric acid solution and kept in a constant temperature water bath for 60-90min;

[0025] a2. Filter while hot and collect the filtrate;

[0026] a3. Add an appropriate amount of activated carbon powder to the filtrate, decolorize at 70-75°C for 20-30 minutes, then filter while hot, collect the filtrate, and repeat the operation until the filtrate is colorless;

[0027] a4. Concentrate the decolorized filtrate to 1 / 4 to 1 / 3 of the filtrate volume and cool it;

[0028] a5. After cooling, the concentrated liquid is added with anhydrous ethanol for alcohol precipitation under constant stirring. The amount of anhydrous ethanol added is 1 to 1.5 times the volume of the concentrated liquid. Let it stand until no flocs are precipitated. After filtering, the pectin solution is obtained.

[0029] Furthermore, the specific preparation method of the bletilla striata pectin phospholipid complex in step (2) is as follows:

[0030] a1. The viscous mixture and lecithin are placed in an ethanol-tetrahydrofuran mixed organic solution for reaction at a temperature of 45 to 55 ° C for 2 to 3 h;

[0031] a2. After the reaction, the organic solvent was recovered by rotary evaporator under reduced pressure, and the residual mixture was freeze-dried in vacuum for 24h to 48h; a3. The dried mixture was added to a sufficient amount of chloroform to be redissolved until completely dissolved, and then filtered through a 0.22μm organic membrane to remove uncomplexed impurities;

[0032] a4. The filtrate obtained is decompressed and chloroform is recovered by a rotary evaporator, and then vacuum freeze-dried for 24h to 48h to obtain the bletilla striata pectin phospholipid complex.

[0033] Furthermore, the self-microemulsification drug delivery system in step (3) comprises the following components: 0.25-0.5 parts by mass of ethyl oleate, 0.55-1.10 parts by mass of a mixed emulsifier composed of polysorbate 80 and HS15 in a mass ratio of 2:1, and 0.2-0.4 parts by mass of anhydrous ethanol, which are mixed to prepare the self-microemulsification drug delivery system;

[0034] Add a sufficient amount of the bletilla striata pectin phospholipid complex into the self-microemulsification drug delivery system, treat with ultrasound for 30 to 60 minutes to facilitate dissolution, and then stir in a 37° C. water bath until a stable transparent liquid is obtained.

[0035] Furthermore, after the transparent liquid in step (4) is cooled to room temperature, the transparent liquid is then added dropwise to an aqueous solution containing carboxymethyl chitosan and acetic acid under the action of an electrostatic field, and then an aqueous solution of sodium citrate is added, and stirring is continued for 1 h to 5 h for secondary crosslinking. During the electrostatic drop process, the syringe push speed is 0.8 mm / min, the needle model is 26G, and the coagulation bath stirring speed is 1200 rpm / min to obtain gel microspheres with a shell structure; the gel microspheres are then allowed to stand at room temperature for 4 days to obtain microporous microspheres that have been settled by gravity.

[0036] Furthermore, in step (5), the microporous microspheres are cured under ultraviolet light, the ultraviolet curing time is 25 min, and the light intensity is 15 W / cm 2, and wash off the shell layer in an alkaline solution of sodium hydroxide, precool it in a refrigerator at 24°C for 18h to 20h, and then put it in a freeze dryer for freeze drying for 12h to 48h to obtain the freeze-dried and dried final product with a microporous structure and a self-microemulsification drug delivery system, namely, the gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata.

[0037] The present invention uses the Bletilla striata-pectin-phospholipid complex as the main component, and the self-microemulsification drug delivery system as the drug carrier for sustained release of Bletilla striata polysaccharide. A microcapsule with a surface concave-convex structure is obtained by electrostatic freeze-drying technology, and a reinforcing film with secondary cross-linking of sodium citrate and carboxymethyl chitosan is coated on the surface of the microcapsule. Compared with the prior art, the present invention has the following beneficial effects:

[0038] (1) The present invention dissolves the mixture of pectin of Bletilla striata polysaccharide and lecithin into a pharmaceutical preparation. Based on the gastric mucosal repair and protection effect of Bletilla striata polysaccharide, the water absorption and swelling characteristics of Bletilla striata and the self-microemulsification drug delivery system are used as drug carriers to enable the drug to have obvious targeted delivery to the surface of gastric ulcers, and to achieve targeted aggregation of Bletilla striata pectin phospholipid complexes at the site of ulcer oxidative stress damage in a gastric ulcer targeting manner, and quickly form a thin film on the surface of the ulcer. The film has strong adhesion and can be closely attached to the surface of the gastric mucosa to continuously play a hemostatic and repairing role. At the same time, the viscosity and mucosal adhesion of pectin are also utilized. With the help of the adhesion of pectin, the drug can be more closely attached to the gastric mucosa, prolonging the drug action time and improving the efficacy.

[0039] (2) The self-microemulsifying drug delivery system SMEDDS of the present invention is a liquid preparation composed of an oil phase, an emulsifier and an emulsifier co-emulsifier, which has good mucosal permeability and biocompatibility, can make the drug have obvious targeted delivery to the surface of gastric ulcer, and realize the targeted aggregation of bletilla striata pectin phospholipid complex at the site of ulcer oxidative stress damage in a gastric ulcer targeting manner; at the same time, it can also effectively cover the damaged gastric mucosa, reduce the stimulation of gastric acid on the gastric mucosa, and thus promote the repair of the gastric mucosa.

[0040] (3) The present invention uses carboxymethyl chitosan-sodium citrate as the microsphere wall material, which can reduce the swelling rate of chitosan microcapsules and reduce the dissolution loss of the viscous mixture of Bletilla striata polysaccharide and pectin. The concave-convex structure on the outer shell surface can achieve accurate drug release in the deep layer of the gastric mucosa, and has the effect of efficient directional hemostasis and repair. The asymmetry and self-driving ability of the concave-convex structure on the surface of the microsphere can well achieve adhesion with the gastric wall and directional propulsion, so that it can more efficiently deliver the gastric mucosal injury treatment drug in the microsphere core, and achieve accurate drug delivery. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1 A schematic diagram of the microscopic morphology of the gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata prepared in the present invention;

[0042] In the figure: 1-inner core layer, 2-outermost layer. DETAILED DESCRIPTION

[0043] The present invention is further described in detail below in conjunction with specific implementations, and the protection scope of the present invention is not limited to the following embodiments.

[0044] The microscopic morphology of the gastric mucosal surface hemostasis repair microsphere capsule based on Bletilla striata provided in this embodiment is as follows: Figure 1 As shown, the whole is spherical, with an overall particle size of 8 to 10 μm, and is coated by an inner core layer 1 and an outermost layer 2, wherein the inner core layer 1 is a Bletilla striata polysaccharide-pectin-lecithin complex; the outermost layer 2 is a carboxymethyl chitosan coating layer, which has a concave-convex structure on the surface, as shown in the figure.

[0045] In this example, the provided gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata was tested for efficacy. The test was conducted on mice with different symptoms, and the fluorescence imaging results and the fluorescence imaging results of the laser confocal microscope were analyzed. The results are as follows:

[0046] Compared with the blank group and the drug group, the fluorescent probe-labeled Bletilla striata pectin phospholipid complex in the drug group was concentrated on the ulcer mucosal surface of the model rats, and the MPO and NO levels in the gastric tissue of the rats in the drug group were significantly reduced (P < 0.01), the GSH level in the gastric tissue was significantly increased (P < 0.01), the SOD activity was stronger, the MDA content was lower, and the drug retention time in the stomach reached 6h, which was significantly longer than that in the stomach of normal rats. Compared with the blank group, the gastric mucosal surface hemostatic repair microsphere capsule provided in this embodiment can effectively repair the ulcer on the gastric surface of mice, and the difference between the two effects is significant.

[0047] The preparation steps of the gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata provided in this embodiment are as follows: (1) Extraction of Bletilla striata polysaccharide

[0048] a1. Soak the dried Bletilla striata stem pieces with distilled water at a mass ratio of 1:3 to 1:10, filter through gauze to remove soluble and insoluble impurities, collect the preliminarily cleaned Bletilla striata stem pieces and dry them in an oven at 30 to 50°C for 18 to 24 hours.

[0049] a2. Soak the Bletilla striata stem pieces that have been initially cleaned and dried in anhydrous ethanol for 1 to 3 hours at a temperature of 20 to 30°C, filter through gauze to remove soluble pigments, collect the Bletilla striata stem pieces and dry them in an oven for 18 to 24 hours.

[0050] a3. Soak the Bletilla striata stems after pigment removal in distilled water at a mass ratio of 1:3 to 1:10 for 0.5 to 3 hours at a temperature of 50 to 90°C. Use a magnetic stirrer to continuously stir the mixture at room temperature for about 2 hours to ensure that it is fully mixed. Transfer the mixture to a hot water bath, heat it to 95°C, and maintain the temperature for 1 hour to improve the extraction efficiency of polysaccharides. After heating, cool the mixture to room temperature.

[0051] a4 centrifuge the mixture to separate the crude polysaccharide solution, collect the supernatant, and filter the supernatant using a filter and filter paper to remove impurities such as residual plant particles.

[0052] a5. Concentrate the filtered solution in an evaporator at low temperature until the volume of the solution is reduced to about 1 / 3 to 2 / 1 of the original volume, add an equal volume of 80% to 100% ethanol to the concentrated solution, mix well, and let stand overnight to precipitate polysaccharides to obtain a Bletilla striata polysaccharide concentrate.

[0053] a6 The precipitate is cleaned 2 to 3 times by static cleaning, flushing cleaning or ultrasonic cleaning, each cleaning time is 1 to 5 minutes, and the cleaned bletilla polysaccharide is placed in an oven for drying at a drying temperature of 40 to 80° C. to obtain dried bletilla polysaccharide.

[0054] (2) Preparation of Bletilla striata polysaccharide solution

[0055] A certain amount of the bletilla striata polysaccharide obtained in step (1) is added to deionized water to prepare a bletilla striata polysaccharide solution with a mass fraction of 3 to 10%, and the solution is stirred at a temperature of 50° C. to 70° C. using a magnetic stirrer for 2 h to 4 h to completely dissolve the bletilla striata polysaccharide in the deionized water, and the solution is placed in a vacuum environment with a vacuum degree of -0.01 to -0.05 Mpa to remove bubbles, thereby obtaining a bletilla striata polysaccharide solution.

[0056] (3) Mixing the Bletilla striata polysaccharide solution with pectin to prepare a viscous mixture

[0057] a1. The pretreated citrus peel was crushed to obtain a powder, and then soaked in a certain concentration of hydrochloric acid solution and kept in a constant temperature water bath for 60-90min;

[0058] a2. Filter while hot and collect the filtrate;

[0059] a3. Add an appropriate amount of activated carbon powder to the filtrate, decolorize at 70-75°C for 20-30 minutes, then filter while hot, collect the filtrate, and repeat the operation until the filtrate is colorless;

[0060] a4. Concentrate the decolorized filtrate to 1 / 4 to 1 / 3 of the filtrate volume and cool it;

[0061] a5. After cooling, the concentrate was stirred continuously and anhydrous ethanol was added for alcohol precipitation. The amount of anhydrous ethanol added was 1 to 1.5 times the volume of the concentrate. The mixture was allowed to stand until no flocs were precipitated. The wet pectin solution was obtained by filtration.

[0062] a6. When both solutions are prepared, slowly pour the Bletilla striata polysaccharide solution into the pectin solution, wherein the Bletilla striata polysaccharide and the pectin solution are mixed in a ratio of 1:1 to 3:1, and continuously and evenly stirred with a magnetic stirrer, and the viscosity of the solution is constantly observed. According to the viscosity requirements, the proportion of Bletilla striata polysaccharide is appropriately increased.

[0063] a7. Let the viscous mixture stand for 40-60 minutes and observe its stability and uniformity. If separation or precipitation is found, stir again or adjust the ratio.

[0064] (4) Preparation of Bletilla striata pectin phospholipid complex

[0065] a1. 1.0g~2.0g of the above mixed viscous mixture of Bletilla polysaccharide and pectin and 1.0~2.0g of lecithin were placed in 40~50mL of ethanol-tetrahydrofuran mixed organic solution for reaction at a temperature of 45~55 ℃ for 2~3h;

[0066] a2. After the reaction, the organic solvent was recovered by rotary evaporator under reduced pressure, and the residual mixture was freeze-dried in vacuum for 24h to 48h;

[0067] a3. The dried mixture was added to 100 mL to 150 mL of chloroform and redissolved until completely dissolved, and then filtered through a 0.22 μm organic membrane to remove uncomplexed impurities;

[0068] a4. The filtrate obtained is decompressed and chloroform is recovered by a rotary evaporator, and then vacuum freeze-dried for 24h to 48h to obtain the bletilla striata pectin phospholipid complex.

[0069] (5) Preparation of microsphere capsules

[0070] a1. Take 0.25g~0.5g of ethyl oleate, 0.55g~1.10 of a mixed emulsifier consisting of polysorbate 80 and HS15 (mass ratio is 2:1), and 0.2g~0.4g of anhydrous ethanol to prepare 1g~2g of a self-microemulsifying drug delivery system (SMEDDS).

[0071] a2. Then add 40mg to 50mg of Bletilla striata pectin phospholipid complex into the self-microemulsifying drug delivery system (SMEDDS), sonicate for 30min to 60min to aid dissolution, and then stir in a 37°C water bath until a stable transparent liquid is obtained.

[0072] a3. Take the transparent liquid from step a2, cool it to room temperature, and then add the mixed solution to the aqueous solution containing carboxymethyl chitosan and acetic acid under the action of an electrostatic field, then add an aqueous solution of sodium citrate, and continue stirring for 1h to 5h for secondary crosslinking to obtain gel microspheres with a shell structure. During the electrostatic drop process, the syringe push speed is 0.8mm / min, the needle model is 26G, and the coagulation bath stirring speed is 1200rpm / min. Then the microspheres are left to stand at room temperature for 4 days to obtain surface convex microspheres after gravity sedimentation;

[0073] a4. The microspheres synthesized in the step are cured under ultraviolet light, the ultraviolet curing time is 25 minutes, the light intensity is 15W / cm2, and the shell layer is washed off in an alkaline sodium hydroxide solution, placed in a -24°C refrigerator for precooling for 18h to 20h, and placed in a freeze dryer for freeze drying for 12h to 48h to obtain freeze-dried and dry carboxymethyl chitosan-bletilla striata pectin microsphere capsules with a surface concave-convex structure and a self-microemulsification drug delivery system, i.e., gastric mucosal surface hemostatic repair microsphere capsules based on bletilla striata.

Claims

1. A gastric mucosal surface hemostasis repair microsphere capsule based on Bletilla striata, characterized in that: The microsphere capsule is prepared by the following method: (1) stirring and mixing the bletilla striata polysaccharide solution and the pectin solution in a volume ratio of 1:1 to 3:1 to obtain a viscous mixture and letting it stand; (2) mixing the viscous mixture and lecithin in an organic solvent at a mass ratio of 1:2 to 2:1, and then removing the organic solvent to obtain a bletilla striata pectin phospholipid complex; (3) adding the bletilla striata pectin phospholipid complex into the self-microemulsion drug delivery system and fully dissolving it to obtain a transparent liquid; (4) adding the transparent liquid dropwise to an aqueous solution containing carboxymethyl chitosan and acetic acid under the action of an electrostatic field, then adding an aqueous solution of sodium citrate, and continuing to stir for secondary crosslinking to obtain gel microspheres with a shell structure, and allowing the gel microspheres to stand at room temperature to obtain microspheres with concave-convex surfaces after gravity sedimentation; (5) The surface convex-concave microspheres are solidified under ultraviolet light, and part of the sodium citrate in the shell layer is washed off in an alkaline solution. After precooling, the microspheres are placed in a freeze dryer for freeze drying, thereby obtaining gastric mucosal surface hemostatic repair microsphere capsules based on Bletilla striata.

2. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: The microsphere capsule is spherical as a whole, with a particle size of 8 to 10 μm, and is coated with an inner core layer and an outermost layer, wherein the inner core layer is a bletilla polysaccharide-pectin-lecithin complex; and the outermost layer is a carboxymethyl chitosan coating layer with a concave-convex surface structure.

3. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: The preparation method of the bletilla striata polysaccharide solution in step (1) is as follows: Add Bletilla striata polysaccharide to deionized water to prepare a Bletilla striata polysaccharide solution with a mass fraction of 3 to 10%, use a magnetic stirrer to stir at a temperature of 50°C to 70°C for 2h to 4h to completely dissolve the Bletilla striata polysaccharide in the deionized water, and place it in a vacuum environment with a vacuum degree of -0.01 to -0.05Mpa to remove bubbles to obtain a Bletilla striata polysaccharide solution.

4. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 3, characterized in that: The extraction method of the bletilla striata polysaccharide is as follows: a1. Soak the dried Bletilla striata stems with distilled water at a mass ratio of 1:3 to 1:10, filter through gauze to remove impurities, collect the preliminarily cleaned Bletilla striata stems and dry them in an oven at 30 to 50°C for 18 to 24 hours; a2. Soak the initially cleaned and dried Bletilla striata stems in anhydrous ethanol for 1 to 3 hours at a temperature of 20 to 30°C, filter through gauze to remove soluble pigments, collect Bletilla striata stems and dry them in an oven for 18 to 24 hours; a3. Take the white striata stems after removing the pigment and soak them in distilled water in a mass ratio of 1:3 to 1:10, soak for 0.5 to 3 hours, soak at a temperature of 50 to 90 ° C, use a magnetic stirrer, stir the mixture continuously at room temperature for about 2 hours to ensure thorough mixing; transfer the mixture to a hot water bath, heat to 95 ° C, maintain the temperature for 1 hour, and after heating, cool the mixture to room temperature; a4. Centrifuge the mixture to separate the crude polysaccharide solution, collect the supernatant, and filter the supernatant using a filter and filter paper to remove residual impurities; a5. The filtered solution was concentrated in an evaporator at low temperature until the volume of the solution was reduced to 1 / 3 to 2 / 1 of the original volume, and an equal volume of 80% to 100% ethanol was added to the concentrated solution, mixed evenly, and allowed to stand overnight to precipitate polysaccharides to obtain a Bletilla striata polysaccharide concentrate; a6. The precipitate is cleaned 2 to 3 times by static cleaning, flushing cleaning or ultrasonic cleaning, each cleaning time is 1 to 5 minutes, and the cleaned Bletilla striata polysaccharide is placed in an oven for drying at a drying temperature of 40 to 80° C. to obtain dried Bletilla striata polysaccharide.

5. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: The preparation method of the pectin solution in step (1) is as follows: a1. The pretreated citrus peel was crushed to obtain a powder, and then soaked in a certain concentration of hydrochloric acid solution and kept in a constant temperature water bath for 60-90min; a2. Filter while hot and collect the filtrate; a3. Add an appropriate amount of activated carbon powder to the filtrate, decolorize at 70-75°C for 20-30 minutes, then filter while hot, collect the filtrate, and repeat the operation until the filtrate is colorless; a4. The decolorized filtrate is concentrated to 1 / 4 to 1 / 3 of the filtrate volume and then cooled; a5. After cooling, the concentrated liquid is added with anhydrous ethanol for alcohol precipitation under constant stirring. The amount of anhydrous ethanol added is 1 to 1.5 times the volume of the concentrated liquid. Let it stand until no flocs are precipitated. After filtering, the pectin solution is obtained.

6. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: The specific preparation method of the bletilla striata pectin phospholipid complex in step (2) is as follows: a1. The viscous mixture and lecithin are placed in an ethanol-tetrahydrofuran mixed organic solution for reaction at a temperature of 45 to 55 ° C for 2 to 3 h; a2. After the reaction, the organic solvent was recovered by rotary evaporator under reduced pressure, and the residual mixture was freeze-dried in vacuum for 24h to 48h; a3. The dried mixture was added to a sufficient amount of chloroform to be redissolved until completely dissolved, and then filtered through a 0.22 μm organic membrane to remove uncomplexed impurities; a4. The filtrate was decompressed and chloroform was recovered by rotary evaporator, and then vacuum freeze-dried for 24h to 48h to obtain the bletilla striata pectin phospholipid complex.

7. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: In step (3), the self-microemulsification drug delivery system comprises the following components: 0.25-0.5 parts by weight of ethyl oleate, 0.55-1.10 parts by weight of a mixed emulsifier composed of polysorbate 80 and HS15 in a mass ratio of 2:1, and 0.2-0.4 parts by weight of anhydrous ethanol, which are mixed to prepare the self-microemulsification drug delivery system; Add a sufficient amount of the bletilla striata pectin phospholipid complex into the self-microemulsification drug delivery system, treat with ultrasound for 30 to 60 minutes to promote dissolution, and then stir in a 37° C. water bath until a stable transparent liquid is obtained.

8. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: After the transparent liquid in step (4) is cooled to room temperature, the transparent liquid is then added dropwise to an aqueous solution containing carboxymethyl chitosan and acetic acid under the action of an electrostatic field, and then an aqueous solution of sodium citrate is added, and stirring is continued for 1 h to 5 h for secondary crosslinking. During the electrostatic drop process, the syringe push speed is 0.8 mm / min, the needle model is 26G, and the coagulation bath stirring speed is 1200 rpm / min to obtain gel microspheres with a shell structure; the gel microspheres are then allowed to stand at room temperature for 4 days to obtain microporous microspheres that have been settled by gravity.

9. The gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1, characterized in that: In step (5), the microporous microspheres are cured under ultraviolet light, the ultraviolet curing time is 25 minutes, and the light intensity is 15W / cm 2 , and wash off the shell layer in an alkaline solution of sodium hydroxide, precool it in a refrigerator at 24°C for 18h to 20h, and then put it in a freeze dryer for freeze drying for 12h to 48h to obtain the freeze-dried and dried final product with a microporous structure and a self-microemulsification drug delivery system, namely, the gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata.

10. Use of the gastric mucosal surface hemostatic repair microsphere capsule based on Bletilla striata according to claim 1 in the preparation of gastric mucosal surface repair and hemostatic drugs.

Citation Information

Patent Citations

  • Preparation method of embedded double-layer bletilla striata dressing

    CN108904865A

  • Gastric retention agent as well as preparation method and application thereof

    CN113171372A

  • Preparation method of pH response type carboxymethyl chitosan / sodium alginate hydrogel ball

    CN113372578A

  • Rhizoma corydalis and rhizoma bletillae stomach-dispersing adhesion pellet and preparation method thereof

    CN116509924A

  • Drug delivery system

    EP0636363A2